Ronald W. Barrett
Independent ChairpersonDr. Ronald W. Barrett, also known as Ron, Ph.D., has been an Independent Director of Janux Therapeutics, Inc. since September 2021 and serves as its Independent Chairperson since July 2024. Dr. Barrett was CEO and Chairman of Medikine, Inc., from June 2017 until January 2023. Dr. Barrett served as Executive Chairman of Medikine, Inc. from January 2023 to July 2023. He had been an Independent Director of Concert Pharmaceuticals, Inc. since December 2007 until June 09, 2022. Dr. Barrett co-founded XenoPort, Inc., in 1999 and served as its Chief Executive Officer since September 2001 until October 1, 2015. Dr. Barrett served as the Chief Scientific Officer of Xenoport Inc. from 1999 to 2001. He served as the Senior Vice President of Research at Affymax Research Institute from 1989 to 1999. He served as a Molecular Pharmacologist in Neuroscience Group at Abbott Laboratories from 1986 to 1989. He has industry and board experience, including as the Chief Executive Officer of a publically traded biopharmaceutical company. Dr. Barrett served as a Director of Xenoport, Inc. since August 1999 to 2015. He serves as Director of Quadriga BioSciences, Inc. He is the inventor on more than 40 U.S. patents and has co-authored over 40 manuscripts in peer-reviewed journals. In 1996, he was co-recipient of the Newcomb-Cleveland Award for the year's best manuscript in the publication Science. Dr. Barrett received B.S. degree in biology from Bucknell University and Ph.D. in Pharmacology from Rutgers University.
Positions
- Company NameJanux Therapeutics, Inc.Stock CodeJANXPositionIndependent ChairpersonColleagues
- DADavid Alan CampbellPresident, Co-Founder, CEO & Director
- TDThomas DiraimondoChief Scientific Officer
- JDJaneen DoyleChief Corporate & Business Development Officer
- MWMatt WhitmireVice President of Finance
- MDMaria DobekVice President of Accounting
- JSJake SimsonIndependent Director
- VLVickie L. CappsIndependent Director
- WKWinston KungIndependent Director
